Genta starts Phase IIb NHL trial

GNTA began a U.S. Phase IIb trial of its gallium nitrate in patients with low- or intermediate-grade non-Hodgkin's lymphoma (NHL) who have low blood counts and who have failed prior chemotherapy and R...